An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer

Radiotherapy and Oncology

Volumn 84, Issue 1, 2007, Pages 11-17

  Shafiq, Jesmin ^a   Delaney, Geoff ^a   Barton, Michael B ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

Breast cancer; Local control; Mortality; Outcome; Radiotherapy; Survival

Indexed keywords

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; MONTE CARLO METHOD; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURVIVAL RATE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34447092820     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.03.006     Document Type: Article

References (35)

1. National Health & Medical Research Council (NHMRC). Clinical practice guidelines for the management of early breast cancer (2nd ed.). Canberra, NHMRC; 2001.
2. National Health & Medical Research Council (NHMRC). Clinical practice guidelines for the management of advanced breast cancer. Canberra, NHMRC; 2001.
3. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
4. Truong P.T., Olivotto I.A., Whelan T.J., et al. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 170 (2004) 1263-1273
5. Shenkier T., Weir L., Levine M., et al. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ 170 (2004) 983-994
6. Van de Steene J., Soete G., and Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol 55 (2000) 263-272
7. Early Breast Cancer Trialists' Collaborative Group. Radiotherapy for early breast cancer. Cochrane Database Syst Rev 2:CD003647; 2002.
8. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
9. Whelan T., and Levine M. More evidence that locoregional radiation therapy improves survival: what should we do? (editorial). J Natl Cancer Inst 97 (2004) 82-84
10. Delaney G., Barton M., and Jacob S. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer 98 (2003) 1977-1986
11. Barbera L., Walker H., Foroudi F., et al. Estimating the benefit and cost of radiotherapy for lung cancer. Int J Technol Assess Health Care 20 (2004) 545-551
12. Barton M.B., Gebski V., Manderson C., et al. Radiation therapy: are we getting value for money?. Clin Oncol (R Coll Radiol) 7 (1995) 287-292
13. Read G. Estimating the cost of radiotherapy. Clin Oncol (R Coll Radiol) 6 (1994) 35-39
14. Glazebrook G.A. Radiation therapy: a long term cost benefit analysis in a North American region. Clin Oncol (R Coll Radiol) 4 (1992) 302-305
15. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28 (2001) 400-418
16. Bijker N., Meijnen P., Peterse J.L., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: ten-year results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 (2006) 3381-3387
17. UK Coordinating Committee on Cancer Research (UKCCCR), Ductal Carcinoma in situ (DCIS) Working Party on behalf of the DCIS trialists in the U.K., Australia and New Zealand. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the U.K., Australia and New Zealand: randomised controlled trial. Lancet 2003;362:95-102.
18. Emdin S.O., Granstrand B., Ringberg A., et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 45 (2006) 536-543
19. Vargas C., Kestin L., Go N., et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys 63 (2005) 1514-1521
20. Vinh-Hung V., and Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96 (2004) 115-121
21. Chagpar A., Meric-Bernstam F., Hunt K.K., et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 10 (2003) 628-634
22. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
23. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (2004) 1641-1648
24. Huang E.H., Tucker S.L., Strom E.A., et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22 (2004) 4691-4699
25. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
26. Moller T.R., Brorsson B., Ceberg J., et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 42 (2003) 387-410
27. Mackillop W.J., Zhou S., Groome P., et al. Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys 44 (1999) 355-362
28. Buchholz T.A., Strom E.A., Perkins G.H., et al. Controversies regarding the use of radiation after mastectomy in breast cancer. Oncologist 7 (2002) 539-546
29. Gebski V., Lagleva M., Keech A., et al. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst 98 (2006) 26-38
30. Clarke M., Collins R., Darby S., et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
31. Lee J.H., Glick H.A., Hayman J.A., et al. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients. J Clin Oncol 20 (2002) 2713-2725
32. Elting L.S., Cooksley C., Bekele B.N., et al. Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer 106 (2006) 2452-2458
33. Dahlberg M., Glimelius B., and Pahlman L. Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Ann Surg 229 (1999) 493-497
34. Yessaian A., Mendivil A.A., and Brewster W.R. Population characteristics in cervical cancer trials: search for external validity. Am J Obstet Gynecol 192 (2005) 407-413
35. Vinh-Hung V., Voordeckers M., Van de Steene J., et al. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol 67 (2003) 147-158